Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Universitätsklinik für Innere Medizin

Klinische Abteilung für Onkologie

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Dutta S, Krause A, Vosberg S, Herold T, Ksienzyk B, Quintanilla-Fend L, Tizazu B, Graf A, Krebs S, Blum H, Greif PA, Schneider M, Dahlhof M, Spiekermann K, Zimber-Strobl U, Wolf E, Bohlander SK Analysis of the Tissue-Specific Expression Requirements and Identification of Cooperating Mutations for Leukemogenesis in an Inducible CALM/AF10 Knock-in Mouse Model
Blood Journal Volume 124, Issue 21 . 2014; -56th ASH Annual meeting (American Society of Hematology) ; Dec 6-9, 2014; San Francisco, USA. [Oral Communication]
FullText

 

** Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134 Doi: 10.1038/tpj.2013.15
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, AL; Koller, K; Salzwimmer, M; Gerger, A; Schauer, S; Bauernhofer, T; Pichler, M Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Hum Pathol. 2014; 45(4):683-690 Doi: 10.1016/j.humpath.2013.11.014
Web of Science PubMed FullText FullText_MUG

 

** Aigner, B; Bauernhofer, T; Petru, E; Niederkorn, A; Arzberger, EJ; Richtig, E Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
Dermatology. 2014; 229(4):288-292 Doi: 10.1159/000365391 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Al-Zoughbi, W; Al-Zhoughbi, W; Huang, J; Paramasivan, GS; Till, H; Pichler, M; Guertl-Lackner, B; Hoefler, G Tumor macroenvironment and metabolism.
Semin Oncol. 2014; 41(2):281-295 Doi: 10.1053/j.seminoncol.2014.02.005 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Andritsch, E., Psychological Detoriation
In: Henk van Halteren editors(s). Rehabilitation Issues during Cancer Treatmentand Follow-Up. Switzerland: ESMO Press; 2014(ISBN: 978-88-906359-5-3)
FullText

 

** Andritsch, E; Farkas, C The Reality of Caregivers of Patients with Cancer in Austria
PSYCHO-ONCOLOGY. 2014; 23: 48-49.-16 World Wongress of Psychooncology and Psychosocial Academy; OCT 20-24; Lissabon, Portugal. [Oral Communication]
Web of Science

 

Bezan, A; Wachstumsfaktoren in der Onkologie - richtiger Einsatz!
Universum Innere Medizin. 2014; 09: 54-56.

 

** Bezan, A; Gerger, A; Pichler, M MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(6):2709-2713
Web of Science PubMed

 

** Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853 Doi: 10.1097/CAD.0000000000000108
Web of Science PubMed FullText FullText_MUG

 

Brookman-May, S; Cindolo, L; Zigeuner, R; Pichler, M; Sountoulides, P; Stief, C; Waidelich, R; Dalpiaz, O; Gilfrich, C; May, M; Schips, L Nierenzellkarzinom-Patienten <80 Jahren haben eine signifikant höhere krebsspezifische und nicht-krebsspezifische Mortalität nach operativer Therapie-Ergebnisse einer komparativen Analyse von Patienten <80 Jahren und Patienten in der 7. Lebensdekade unter Integration von Competing-Risks-Analysen
J Urol Urogynäkol. 2014; 21(4):10-10.-40. Gemeinsame Tagung der Bayerischen Urolgenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; MAY 15-17, 2014; Erlangen, GERMANY. [Oral Communication]

 

Brookman-May, SD; Ficarra, V; Shariat, S; Zigeuner, R; Chromecki, T; Cindolo, L; Gunia, S; Aziz, A; Otto, W; Pahernik, S; Chun, F; Becker, A; Simeone, C; Longo, N; Zucchi, A; Stabiano, S; D'Alterio, C; Gilfrich, C; Schips, L; De Cobelli, O; Joniau, S; Waidelich, R; Pichler, M; Rocco, B; Tubaro, A; Feciche, B; Truss, M; Dalpiaz, O; Zastrow, S; Wirth, M; Santiago Martin, M; Hoschke, B; Stief, C; May, M Prognostic influence of chromophobe subtype and sarcomatoid dedifferentiation in patients with renal cell carcinoma and impact of clinical and histopathological parameters on disease-specific survival in patients with collecting duct renal cell carcinoma (CDRCC): Results of comprehensive analyses of the CORONA and SATURN databases and development of a disease-specific risk-model for CDRCC patients
Eur Urol Suppl 2014. 2014; 13(1):e317-e317.-29th Annual EAU Congress; APR 11-15, 2014; Stockholm, SWEDEN. [Poster]

 

Brookman-May, SD; Zigeuner, R; Sountoulides, P; Truss, M; Dalpiaz, O; Wolff, I; Hoschke, B; Gilfrich, C; Pichler, M; Waidelich, R; Stief, C; Cindolo, L; Schips, L; May, M Nierenzellkarzinom-Patienten ≥80 Jahren haben eine signifikant höhere krebsspezifische und nicht-krebsspezifische Mortalität nach operativer Therapie als Patienten im typischen Erstdiagnosealter zwischen 60 und 70 Jahren – Ergebnisse einer komparativen Analyse dieser Altersgruppen unter Integration von Competing-Risks-Analysen
Der Urologe Suppl. 2014; 53(1):114-114.-66. Kongress der Deutschen Gesellschaft für Urologie e.V.; OCT 1-4, 2014; Düsseldorf, GERMANY. [Oral Communication]

 

** Dalpiaz, O; Ehrlich, GC; Mannweiler, S; Hernández, JM; Gerger, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
BJU Int. 2014; 114(3):334-339 Doi: 10.1111/bju.12441 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mannweiler, S; Martín Hernández, JM; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Br J Cancer. 2014; 110(10):2531-2536 Doi: 10.1038/bjc.2014.180 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Deutsch, AJ; Rinner, B; Wenzl, K; Pichler, M; Troppan, K; Steinbauer, E; Schwarzenbacher, D; Reitter, S; Feichtinger, J; Tierling, S; Prokesch, A; Scheideler, M; Krogsdam, A; Thallinger, GG; Schaider, H; Beham-Schmid, C; Neumeister, P NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Blood. 2014; 123(15):2367-2377 Doi: 10.1182/blood-2013-08-518878 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Filipits, M; Nielsen, TO; Rudas, M; Greil, R; Stöger, H; Jakesz, R; Bago-Horvath, Z; Dietze, O; Regitnig, P; Gruber-Rossipal, C; Müller-Holzner, E; Singer, CF; Mlineritsch, B; Dubsky, P; Bauernhofer, T; Hubalek, M; Knauer, M; Trapl, H; Fesl, C; Schaper, C; Ferree, S; Liu, S; Cowens, JW; Gnant, M; Austrian Breast and Colorectal Cancer Study Group The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res. 2014; 20(5):1298-1305 Doi: 10.1158/1078-0432.CCR-13-1845 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fitzal, F; Filipits, MF; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Bartsch, R; Leitner, G; Gnant, M; Tailoring local therapy in post-menopausal endocrine responsive HER2neu negative breast cancer patients based on their genetic risk profile using Endopredict.
EUR J CANCER. 2014; 50: S97-S97.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
Web of Science

 

** Friesenbichler, J; Leithner, A; Maurer-Ertl, W; Szkandera, J; Sadoghi, P; Frings, A; Maier, A; Andreou, D; Windhager, R; Tunn, PU Surgical therapy of primary malignant bone tumours and soft tissue sarcomas of the chest wall: a two-institutional experience.
Int Orthop. 2014; 38(6):1235-1240 Doi: 10.1007/s00264-014-2304-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Friesenbichler, J; Maurer-Ertl, W; Sadoghi, P; Szkandera, J; Pirker-Frühauf, U; Weger, C; Leithner, A Serum metal ion concentrations following mega¬prosthetic knee replacement for tumour indications: Is there a matter of concern?
Abstract Book of the 10th CEOC, P-26. 2014; -10th Central European Orthopaedic Congress & Congress of the Croatian Orthopaedic and Traumatology Association; MAY 8-11, 2014; Split, CROATIA. [Poster]

 

** Friesenbichler, J; Sadoghi, P; Maurer-Ertl, W; Szkandera, J; Glehr, M; Ogris, K; Wolf, M; Weger, C; Leithner, A Serum metal ion concentrations in paediatric patients following total knee arthroplasty using megaprostheses.
Biomed Res Int. 2014; 2014(6):817257-817257 Doi: 10.1155/2014/817257 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gary, T; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Haas, E; Eller, P; Brodmann, M Elevated blood urea nitrogen is associated with CLI in PAOD patients
EUR HEART J. 2014; 35: 631-631.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN.
Web of Science

 

** Gary, T; Pichler, M; Belaj, K; Eller, P; Hafner, F; Gerger, A; Brodmann, M Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients.
Int J Clin Pract. 2014; 68(12):1483-1487 Doi: 10.1111/ijcp.12495
Web of Science PubMed FullText FullText_MUG

 

Glehr, M; Friesenbichler, J; Bernhardt, GA; Windhager, R; Hofmann, G; Szkandera, J; Avian, A; Leithner, A Novel Biomarkers to Detect Infection in Orthopedic Revision Arthroplasty.
Abstractbook of EMSOS 2014, P10.01. 2014; 62--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Poster]

 

** Glehr, M; Kaltenbach, A; Glehr, R; Sadoghi, P; Leithner, A; Gruber, G; Szkandera, J; Ludt, S; Vielgut, I; Glehr, R; Wensing, M Physician awareness of knee and hip pain in the context of coronary heart disease treatment.
ScientificWorldJournal. 2014; 2014(4):494801-494801 Doi: 10.1155/2014/494801 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO; Austrian Breast and Colorectal Cancer Study Group Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol. 2014; 25(2):339-345 Doi: 10.1093/annonc/mdt494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Goldzweig, G; Baider, L; Andritsch, E An Unexpected Outcome: Psychological Distress among Israeli Cancer Patients and Their Spousal Caregivers
PSYCHO-ONCOLOGY. .. 2014; 23: 45-45.-16th World Congress of Psychooncology and PSychosocial Academy; OCT 20-24; Lissabon, Portugal. [Oral Communication]
Web of Science

 

** Heitzer, E; Artl, M; Filipits, M; Resel, M; Graf, R; Weißenbacher, B; Lax, S; Gnant, M; Wrba, F; Greil, R; Dietze, O; Hofbauer, F; Böhm, G; Höfler, G; Samonigg, H; Schaberl-Moser, R; Balic, M; Dandachi, N Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Mod Pathol. 2014; 27(6):906-915 Doi: 10.1038/modpathol.2013.204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Heitzer, E; Mohan, S; Ulz, P; Lafer, I; Auer, M; Lax, S; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR; Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
EUR J CANCER. 2014; 50: S96-S96.-EACR 2014; München. Doi: 10.1016/S0959-8049(14)50357-7 [Poster]
Web of Science FullText FullText_MUG

 

Heu, C; Strenger, V; Friesenbichler, J; Szkandera, J; Leithner, A Methotrexat Konzentrationen bei Osteosarkom Patienten in Dritträumen.
Abstractband des DKOU 2014. 2014; -DKOU 2014; OCT 28-31, 2014; Berlin, GERMANY. [Oral Communication]

 

Hofmann, G; Klammer, M; Jahn-Kuch, D; Bitsche, S; Edelsbrunner, M; Verebes, J; Siegl, A; Kuba, S; Sandner-Kiesling, A; Samonigg, H Outcome Quality of Pain Management on a Palliatve Care Unit as a Result of a Certification Process
Palliative Medicine. 2014; 28(6):862-862.-8 th World Research Congress of the European Association for Palliative Care (EAPC); JUNE 5-7, 2014; Lleida, SPAIN. [Poster]

 

Hutterer, GC; Dalpiaz, O; Sobolev, N; Martín Hernández, JM; Stojakovic, T; Eberhard, K; Mannweiler, S; Pummer, K; Zigeuner, R; Pichler, M Validierung der präoperativen Lymphozyten-Monozyten-Ratio (LMR) als Prognosefaktor beim Urothelkarzinom des oberen Harntraktes in einer europäischen Single-Center-Serie
Der Urologe 2014;(53)Suppl 1: 81.. 2014; - 66. Kongress der Deutschen Gesellschaft für Urologie e.V.; OCT 1-4, 2014; Düsseldorf, Germany. [Oral Communication]

 

Hutterer, GC; Stöckigt, C; Stojakovic, T; Martín Hernández, JM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Zigeuner, R; Pichler, M High pre-operative monocyte-lymphocyte ratio (MLR) represents a poor prognostic factor in non-metastatic clear cell renal cell carcinoma
Eur Urol Suppl 2014;13;e320. 2014; -29th Annual EAU (European Association of Urology) Congress ; APR 11-15; Stockholm, SE. [Poster]

 

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4): Doi: 10.1200/jco.2014.32.4_suppl.534 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Jesche, J; Eberhard, K; Pummer, K; Zigeuner, R; Pichler, M Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Urol Oncol. 2014; 32(7):1041-1048 Doi: 10.1016/j.urolonc.2014.04.001
Web of Science PubMed FullText FullText_MUG

 

Jahn-Kuch, D; Hofmann, G; Pachmajer, J Das Fatigue-Syndrom.
Krebshilfe. 2014; (6:2014): 32-36.

 

Kainhofer, V; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A Local recurrences after resection of soft tissue sarcomas: a multifactorial analysis.
Abstractbook of EMSOS 2014, 02.02. 2014; 9--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Oral Communication]

 

Kainhofer, V; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A LOCAL RECURRENCES OF SOFT TISSUE SARCOMAS: R-CLASSIFICATION VERSUS UICC-CLASSIFICATION OF RESECTION MARGINS.
Abstracts of CTOS 2014 Annual Meeting, P 253. 2014; 293--CTOS 2014 Annual Meeting; OCT 15-18, 2014; Berlin, GERMANY. [Poster]

 

** Kammerer, S; Sokolowski, A; Hackl, H; Jahn, S; Asslaber, M; Symmans, F; Peintinger, F; Regitnig, P; Schreibmayer, W; Bauernhofer, T OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER
ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM. Doi: 10.1093/annonc/mdu066.21 [Poster]
Web of Science FullText FullText_MUG

 

** Keil, F; Selzer, E; Berghold, A; Reinisch, S; de Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsasser, W; Kainz, H; Riedl, R; Kapp, K; Kopp, M; Kornek, G Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
ONCOL RES TREAT. 2014; 37: 273-273.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie.; Oct 10-14, 2014; Hamburg, Deutschland. [Oral Communication]
Web of Science

 

** Kluth, LA; Shariat, SF; Kratzik, C; Tagawa, S; Sonpavde, G; Rieken, M; Scherr, DS; Pummer, K The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.
World J Urol. 2014; 32(3):669-676 Doi: 10.1007/s00345-013-1157-5
Web of Science PubMed FullText FullText_MUG

 

** Koller, K; Pichler, M; Koch, K; Zandl, M; Stiegelbauer, V; Leuschner, I; Hoefler, G; Guertl, B Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1.
Pediatr Dev Pathol. 2014; 17(3):169-175 Doi: 10.2350/13-01-1288-OA.1
Web of Science PubMed FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
Br J Cancer. 2014; 110(10):2524-2530 Doi: 10.1038/bjc.2014.163 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative platelet to lymphocyte ratio is an independent prognostic marker in breast cancer patients
EUR J CANCER. 2014; 50: S213-S213.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

Krenn-Pilko S., Langsenlehner U., Thurner E.-M., Stojakovic T., Pichler M., Gerger A., Kapp K.S., Langsenlehner T. Der präoperativ erhöhte Plasma-Fibrinogen-Spiegel ist als prädiktiver Faktor für die Prognose von Brustkrebs Patientinnen
Abstractband ÖGRO / BAYRO 2014. 2014; -31. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und medizinische Radiophysik. 2014; -ÖGRO / BAYRO 2014. 2014; -31. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und medizinische Radiophysik; OKT 3-4, 2014; Innsbruck, AUSTRIA. [Poster]

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T; Elevated plasma fibrinogen levels as an independent prognostic marker in breast cancer patients.
STRAHLENTHER ONKOL. 2014; 190: 26-26.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY. [Oral Communication]
Web of Science

 

** Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; The preoperative Platelet/Lymphocyte Ratio is a predictive Factor for the Prognosis of Female Breast Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

** Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; Effect of Pentoxifylline on the Expression of IL1 beta and NF-kappa B in the Oral Mucous Membrane (Mouse) during fractionated Irradiation.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

Kuepper, MK; Wolf, O; Huber-Krassnitzer, B; Wieser, R; Pichler, M; Scheideler, M; Woelfler, A; Sill, H; Zebisch, A Overexpression of miR-23a, miR-24 and miR-15a in acute myeloid leukemia with loss of the RAF kinase inhibitor protein.
memo-magazine of european medical oncology 2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA. [Oral Communication]

 

Landsmann, B; Pinter, D; Pirker, E; Pichler, G; Schippinger, W; Ropele, S; Reiter, G; Gattringer, T; Fazekas, F; Enzinger, C Änderungen zerebraler Aktivität in der funktionellen MRT begleiten klinische Funktionsverbesserungen nach Training beim chronischen lakunären Schlaganfall
Neurologisch. 2014;

 

** Langsenlehner, T; Thurner, EM; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.
Strahlenther Onkol. 2014; 190(4):364-369 Doi: 10.1007/s00066-013-0503-2
Web of Science PubMed FullText FullText_MUG

 

** Li, CY; Rezania, S; Kammerer, S; Gorischek, A; Bauernhofer, T; Schreibmayer, W Mechano-Sensitive Ion Channels (MSCS) Provide Human Breast Cancer Cells with a Sensorium for Mechanical Stress.
BIOPHYS J. 2014; 106(2):549A-550A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA. Doi: 10.1016/j.bpj.2013.11.3061 [Poster]
Web of Science FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Koesslbacher, M; Pichler, M; Stojakovic, T; Roller, RE; Maier, A; Anegg, U; Smolle, J; Smolle-Juettner, FM The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
J Surg Oncol. 2014; 110(6):645-650 Doi: 10.1002/jso.23711
Web of Science PubMed FullText FullText_MUG

 

** Mohan, S; Heitzer, E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler, M; Gerger, A; Eisner, F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
PLoS Genet. 2014; 10(3):e1004271-e1004271 Doi: 10.1371/journal.pgen.1004271 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539 Doi: 10.1158/1535-7163.MCT-13-0646 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Páez, D; Gerger, A; Zhang, W; Yang, D; Labonte, MJ; Benhanim, L; Kahn, M; Lenz, F; Lenz, C; Ning, Y; Wakatsuki, T; Loupakis, F; Lenz, HJ Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.
Pharmacogenomics J. 2014; 14(2):142-150 Doi: 10.1038/tpj.2013.20
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Dalpiaz, O; Ehrlich, GC; Stojakovic, T; Martín Hernández, JM; Mannweiler, S; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
J Urol. 2014; 191(4):920-925 Doi: 10.1016/j.juro.2013.10.073
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Ress, AL; Winter, E; Stiegelbauer, V; Karbiener, M; Schwarzenbacher, D; Scheideler, M; Ivan, C; Jahn, SW; Kiesslich, T; Gerger, A; Bauernhofer, T; Calin, GA; Hoefler, G MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Br J Cancer. 2014; 110(6):1614-1621 Doi: 10.1038/bjc.2014.51 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203 Doi: 10.1136/jclinpath-2013-201904
Web of Science PubMed FullText FullText_MUG

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.2284.2284
Web of Science FullText FullText_MUG

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstoker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.3681.3681
Web of Science FullText FullText_MUG

 

** Popescu, RA; Schäfer, R; Califano, R; Eckert, R; Coleman, R; Douillard, JY; Cervantes, A; Casali, PG; Sessa, C; Van Cutsem, E; de Vries, E; Pavlidis, N; Fumasoli, K; Wörmann, B; Samonigg, H; Cascinu, S; Cruz Hernández, JJ; Howard, AJ; Ciardiello, F; Stahel, RA; Piccart, M The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).
Ann Oncol. 2014; 25(1):9-15 Doi: 10.1093/annonc/mdt522 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Posch, F; Ay, C; Kaider, A; Zielinski, C; Pabinger, I Estimating rates of venous thromboembolism in patients with cancer using the Kaplan-Meier and competing-risk approach: insights from the Vienna Cancer and Thrombosis Study.
Thrombosis Research, Volume 133, Supplement 2, Pages S1-S228.. 2014; 190-190.-7th International Conference on Thrombosis and Hemostasis Issues in Cancer; MAY 9-11, 2014; Bergamo, ITALY. [Poster]
FullText

 

** Regierer, AC; Wolters, R; Ufen, MP; Weigel, A; Novopashenny, I; Köhne, CH; Samonigg, H; Eucker, J; Possinger, K; Wischnewsky, MB An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.
Ann Oncol. 2014; 25(3):633-638 Doi: 10.1093/annonc/mdt539 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502 Doi: 10.18632/oncotarget.2329 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rezania, S; Li, CY; Kammerer, S; Gorischek, A; Devaney, T; Zarnani, AH; Bauernhofer, T; Schreibmayer, W; G-Protein Activated Inwardly Rectifying Potassium Channels Control Motility of Breast Cancer Cells.
BIOPHYS J. 2014; 106(2):543A-543A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA. Doi: 10.1016/j.bpj.2013.11.3026 [Poster]
Web of Science FullText FullText_MUG

 

Riedl, J; Kaider, A; Posch, F; Koder, S; Reitter, EM; Marosi, C; Zielinski, C; Pabinger, I; Ay, C; Association of soluble CD40 ligand and thrombospondin-1 with cancer-associated venous thromboembolism.
Thrombosis Research, Volume 133, Supplement 2, Pages S1-S228. 2014; 205-206.-7th International Conference on Thrombosis and Hemostasis Issues in Cancer; MAY 9-11, 2014; Bergamo, ITALY. [Poster]
FullText

 

Rief, P; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Eller, P; Brodmann, M; Gary, T Elevated Blood Urea Nitrogen is Associated with CLI in PAOD Patients
Zeitschrift für Gefäßmedizin. 2014; -Sailersymposium; Jun 12-13, 2014; Graz. [Poster]

 

** Rogen, S; Hofmann, P; Bauernhofer, T; Müller, W Evaluation of the physical activity biography: sport and transport.
J Sports Sci Med. 2014; 13(2):338-348 [OPEN ACCESS]
Web of Science PubMed PUBMED Central

 

Samonigg, H; Fazekas, F; Gastl, G; Gaugg, M; Greil, R; Holzer, P; Jäger, U; Katzenschlager, R; Leeb, B; Mamoli, B; Müller, M; Noe, CR; Novacek, G; Petritsch, W; Pohanka, E; Redlich, K; Riedl, E; Rosenkranz, A; Steger, G; Tanew-Iliitschew, A; Tilg, H Biosimilars – aktueller Stellenwert.
Österreichische Ärztezeitung. 2014; Suppl. Mai 2014: 1-11.

 

Samonigg, H; Fazekas, F; Gastl, G; Gaugg, M; Greil, R; Holzer, P; Jäger, U; Katzenschlager, R; Leeb, B; Mamoli, B; Müller, M; Noe, CR; Novacek, G; Petritsch, W; Pohanka, E; Redlich, K; Riedl, E; Rosenkranz, A; Steger, G; Tanew-Iliitschew, A; Tilg, H Biosimilars - aktueller Stellenwert.
Intrinsic Activity. 2014; 2(1): e4 Doi: 10.25006/IA.2.1-e4
FullText FullText_MUG

 

Schaffler, A; Andreou, D; Tunn, PU; Szkandera, J; Maurer-Ertl, W; Leithner, A Intra-abdominelle und retroperitoneale Metastasen bei 613 Patienten und Patientinnen mit Weichteilsarkom - eine 2-Zentren-Studie.
Abstractband des DKOU 2014. 2014; -DKOU 2014; OCT 28-31, 2014; Berlin, GERMANY. [Poster]

 

Schnitzlein, H Stress Reactivity of Physically Active Pregnant Women: Social Support, Physical Activity, and its Effect on the Arousal of the Autonomic Nervous System
Humanmedizin; [ Diplomarbeit ] Medical University of Graz; 2014. pp. 116 [OPEN ACCESS]
FullText

 

Schnitzlein, HD; Trapp, EM; Csapo, B; Egger, JW The impact of social support within healthy and physically active pregnant women.
Psychologische Medizin. 2014; 25(4): 9-17.

 

Schnitzlein, HD; Trapp, EM; Csapo, B; Egger JW The Impact of Social Support on Healthy and Physically Active Pregnant Women.
Psychologische Medizin. 2014; Volume 25(4): 9-17.

 

** Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Najima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Geigl, JB; Höfler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X
Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 ) [Oral Communication]
Web of Science

 

** Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Nojima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Heitzer, E; Geigl, JB; Windpassinger, C; Hoefler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.
Nat Commun. 2014; 5(10):5191-5191 Doi: 10.1038/ncomms6191 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Sereinigg, M; Puntschart, A; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Stadelmeyer, E; Dandachi, N; Stadlbauer-K, V; Iberer, F; Stiegler, P Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD).
AM J TRANSPLANT. 2014; 14: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. [Poster]
Web of Science

 

** Sereinigg, M; Puntschart, A; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Stadelmeyer, E; Dandachi, N; Stadlbauer-K, V; Iberer, F; Stiegler, P; Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD).
TRANSPLANTATION. 2014; 98: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. [Poster]
Web of Science

 

** Smolle, M; Uranitsch, S; Gerger, A; Pichler, M; Haybaeck, J Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer.
Int J Mol Sci. 2014; 15(8):13993-14013 Doi: 10.3390/ijms150813993 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stadelmeyer, E; Heitzer, E; Resel, M; Cerroni, L; Wolf, P; Dandachi, N The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.
J Invest Dermatol. 2014; 134(2):548-550 Doi: 10.1038/jid.2013.338 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
ANN ONCOL. 2014; 25(2): 366-371. Doi: 10.1093/annonc/mdt508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stiegelbauer, V; Perakis, S; Deutsch, A; Ling, H; Gerger, A; Pichler, M MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
World J Gastroenterol. 2014; 20(33):11727-11735 Doi: 10.3748/wjg.v20.i33.11727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Pichler, M; Absenger, G; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
Br J Cancer. 2014; 110(2):435-440 Doi: 10.1038/bjc.2013.785 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
PLoS One. 2014; 9(8):e104730-e104730 Doi: 10.1371/journal.pone.0104730 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Sunakawa, Y; Wakatsuki, T; Yang, D; Zhang, W; Ning, Y; Stintzing, S; Stremitzer, S; Yamauchi, S; Sebio, A; El-khoueiry, R; Iqbal, S; Barzi, A; Gerger, A; Stotz, M; Azuma, M; Watanabe, M; Koizumi, W; Lenz, HJ Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients.
Pharmacogenet Genomics. 2014; 24(12):588-596 Doi: 10.1097/FPC.0000000000000091 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Suppan, C; Bjelic-Radisic, V; La Garde, M; Samonigg, H; Dandachi, N; Balic, M N/L Ratio does not have predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
EUR J CANCER. 2014; 50: S193-S193.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

** Suppan, C; Milkovic, L; Gasparovic, AC; Samonigg, H; Dandachi, N; Balic, M Higher levels of HNE are associated with disease aggressiveness and worse outcome in breast cancer patients
EUR J CANCER. 2014; 50: S70-S70.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

Suppan, C; Steger, G; Balic, M; Dandachi, N; Lang, A; Mlineritsch, B; Fesl,C; Samonigg, H; Gnat,M; Bauernhofer,T; Evaluation of soluble E-Cadherin as a predictive marker for response to preoperative systemic chemotherapy in early breast cancer
Annals of Oncology Supplement 2014. 2014; -IMPAKT; May 7-10, 2014; Brussels, Belgium. [Poster]

 

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Abstractbook of EMSOS 2014, P02.04. 2014; 44--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Poster]

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Int J Cancer. 2014; 135(2):362-370 Doi: 10.1002/ijc.28677 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Leithner, A; Pichler, M Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
PLoS One. 2014; 9(9):e107297-e107297 Doi: 10.1371/journal.pone.0107297 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Kornprat, P; Stojakovic, T; Avian, A; Gerger, A The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
Am J Surg. 2014; 208(2):210-214 Doi: 10.1016/j.amjsurg.2013.10.030
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Clin Cancer Res. 2014; 20(6):1687-1697 Doi: 10.1158/1078-0432.CCR-13-1517 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144 Doi: 10.1002/jso.23458
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Stotz, M; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Lackner, C; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Br J Cancer. 2014; 110(1):183-188 Doi: 10.1038/bjc.2013.701 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Gerger, A; Pichler, M; Kapp, KS; Langsenlehner, U; Langsenlehner, T The elevated C-reactive protein (CRP) level is a poor prognostic factor in prostate cancer patients
ONCOL RES TREAT. 2014; 37: 179-179.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2014.; OCT 10-14, 2014; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T C-reaktives Protein (CRP) als prognostischer Marker bei nicht metastasierten Prostata Karzinompatienten.
Abstract-Band DEGRO 2014 Strahlentherapie und Onkologie. 2014; 190 (1):-20. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; Jul 3-6, 2014; Düsseldorf, Germany . [Poster]

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Strahlenther Onkol. 2014; 190(3):304-309 Doi: 10.1007/s00066-013-0485-0
Web of Science PubMed FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T; Relation between Polymorphisms in the Apoptotic Genes FAS and FASL and radiogenic Long-Terms-Effects in Prostate Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):127-127.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, K; Langsenlehner, T C-reactive Protein (CRP) as a prognostic Marker in non-metastatic Prostate Cancer Patients
STRAHLENTHER ONKOL. 2014; 190: 61-61.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY. [Poster]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Elevated C-reactive protein level predicts poor prognosis in prostate cancer patients treated with radiotherapy.
Journal of the European Society for Radiotherapy and Oncology.. 2014; 111(Supp 1):129-129.-ESTRO 33; APR 4-8, 2014; Vienna, AUSTRIA. [Oral Communication]

 

** Troppan, K; Deutsch, A; Gerger, A; Stojakovic, T; Beham-Schmid, C; Wenzl, K; Neumeister, P; Pichler, M The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Br J Cancer. 2014; 110(2):369-374 Doi: 10.1038/bjc.2013.763 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, K; Wenzl, K; Deutsch, A; Ling, H; Neumeister, P; Pichler, M MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(2):557-564
Web of Science PubMed

 

** Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135. [Poster]
Web of Science

 

Troppan K; Wenzl K; Deutsch A; Schwarzenbacher D; Pichler M; Graupp M; Neumeister P Hohe Expression von microRNA-199a_1 und microRNA-497_1 ist assoziiert mit besserem Überleben bei patienten mit aggressivem non-Hodgkin-Lymphom
Memo magazine of european medical oncology Proceedings of the annual meeting of the Austrian society of haematology and medical oncology. 2014; 7(1):14-15.-Frühjahrstagung ÖGHO; APR 10-12, 2014; Innsbruck. [Poster]

 

** Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Br J Cancer. 2014; 111(1):55-60 Doi: 10.1038/bjc.2014.277 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Vosberg, S; Herold, T; Metzeler, KH; Schneider, S; Ksienzyk, B; Graf, A; Krebs, S; Blum, H; Spiekermann, K; Bohlander, SK; Mansmann, U; Greif, PA Copy Number Alteration (CNA) Analysis in Targeted Sequencing Data from Acute Myeloid Leukemia (AML) Patients with Chromosome 9q Deletion.
Blood. 2014; 124(21):-56th Annual Meeting of the American Society of Hematology; DEC 6-9, 2014; San Francisco, USA. [Poster]
FullText

 

** Wagner, A; Mayr, C; Bach, D; Illig, R; Plaetzer, K; Berr, F; Pichler, M; Neureiter, D; Kiesslich, T MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Int J Mol Sci. 2014; 15(11):20134-20157 Doi: 10.3390/ijms151120134 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

© Med Uni Graz Impressum